Disc Medicine (IRON) News Today $54.52 +0.17 (+0.31%) Closing price 03:59 PM EasternExtended Trading$54.58 +0.06 (+0.12%) As of 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Disc Medicine, Inc. (NASDAQ:IRON) COO Sells $87,873.80 in StockFebruary 21 at 7:09 AM | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Short Interest UpdateDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) saw a significant growth in short interest in the month of January. As of January 31st, there was short interest totalling 2,170,000 shares, a growth of 6.4% from the January 15th total of 2,040,000 shares. Approximately 12.1% of the shares of the company are short sold. Based on an average daily volume of 336,500 shares, the short-interest ratio is presently 6.4 days.February 18 at 11:03 PM | marketbeat.comShort Interest in Disc Medicine, Inc. (NASDAQ:IRON) Increases By 6.4%February 18 at 2:57 AM | americanbankingnews.comDisc Medicine FY2025 EPS Forecast Boosted by Leerink PartnrsFebruary 12, 2025 | americanbankingnews.comBleakley Financial Group LLC Acquires Shares of 7,667 Disc Medicine, Inc. (NASDAQ:IRON)Bleakley Financial Group LLC acquired a new stake in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,667 shares of the company's stock, valued at approximatelFebruary 11, 2025 | marketbeat.comStifel Nicolaus Reaffirms Their Buy Rating on Disc Medicine (IRON)February 10, 2025 | markets.businessinsider.comLeerink Partnrs Expects Increased Earnings for Disc MedicineDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at Leerink Partnrs boosted their FY2025 earnings per share (EPS) estimates for Disc Medicine in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will post earnings perFebruary 10, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Insider Sells 7,500 Shares of StockFebruary 5, 2025 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) Insider Rahul Khara Sells 7,500 SharesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider Rahul Khara sold 7,500 shares of Disc Medicine stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $55.54, for a total transaction of $416,550.00. Following the sale, the insider now owns 14,035 shares of the company's stock, valued at approximately $779,503.90. The trade was a 34.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.February 4, 2025 | marketbeat.comShort Interest in Disc Medicine, Inc. (NASDAQ:IRON) Increases By 6.6%Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) was the recipient of a significant increase in short interest in the month of January. As of January 15th, there was short interest totalling 1,770,000 shares, an increase of 6.6% from the December 31st total of 1,660,000 shares. Currently, 11.3% of the company's shares are sold short. Based on an average daily volume of 316,200 shares, the days-to-cover ratio is presently 5.6 days.February 4, 2025 | marketbeat.comPromising Growth for Disc Medicine: Buy Rating Backed by Strategic Advancements and Clinical ProgressJanuary 29, 2025 | markets.businessinsider.comDisc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of "Buy" by BrokeragesDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has earned an average rating of "Buy" from the ten analysts that are currently covering the company, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the comJanuary 29, 2025 | marketbeat.comStifel Nicolaus Keeps Their Buy Rating on Disc Medicine (IRON)January 24, 2025 | markets.businessinsider.comStifel raises Disc Medicine stock target to $94, maintains BuyJanuary 24, 2025 | msn.comStifel Nicolaus Issues Positive Forecast for Disc Medicine (NASDAQ:IRON) Stock PriceStifel Nicolaus lifted their target price on shares of Disc Medicine from $90.00 to $94.00 and gave the stock a "buy" rating in a research note on Friday.January 24, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Sees Large Volume Increase After Analyst UpgradeDisc Medicine (NASDAQ:IRON) Sees Unusually-High Trading Volume Following Analyst UpgradeJanuary 23, 2025 | marketbeat.comBrokers Offer Predictions for Disc Medicine FY2026 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Wedbush upped their FY2026 earnings per share estimates for shares of Disc Medicine in a research report issued to clients and investors on Tuesday, January 21st. Wedbush analyst D. Nierengarten now forecasts that the company will post earnings peJanuary 23, 2025 | marketbeat.comDisc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded WarrantsJanuary 22, 2025 | globenewswire.comDisc Medicine price target raised to $73 from $70 at ScotiabankJanuary 22, 2025 | markets.businessinsider.comDisc Medicine (NASDAQ:IRON) Shares Gap Down - Here's What HappenedDisc Medicine (NASDAQ:IRON) Shares Gap Down - Here's WhyJanuary 22, 2025 | marketbeat.comDisc Medicine (NASDAQ:IRON) Price Target Raised to $73.00 at ScotiabankScotiabank increased their price objective on Disc Medicine from $70.00 to $73.00 and gave the company a "sector outperform" rating in a report on Wednesday.January 22, 2025 | marketbeat.comFY2028 Earnings Estimate for Disc Medicine Issued By WedbushDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Research analysts at Wedbush lifted their FY2028 earnings estimates for shares of Disc Medicine in a research report issued on Tuesday, January 21st. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of $7.51 perJanuary 22, 2025 | marketbeat.comCantor Fitzgerald Estimates Disc Medicine FY2025 EarningsDisc Medicine, Inc. (NASDAQ:IRON - Free Report) - Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Disc Medicine in a report released on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska anticipates that the company will earn ($5.24) per share for the yearJanuary 22, 2025 | marketbeat.comDisc Medicine’s Bitopertin: Regulatory Progress and Accelerated Market Prospects Fuel Buy RatingJanuary 22, 2025 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Disc Medicine (IRON)January 22, 2025 | markets.businessinsider.comDisc Medicine’s Promising Path: Buy Rating Backed by Regulatory Milestones and Market PotentialJanuary 22, 2025 | markets.businessinsider.comDisc Medicine: Potential Promise Amid UncertaintyJanuary 22, 2025 | seekingalpha.comDisc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsJanuary 21, 2025 | globenewswire.comHC Wainwright Reiterates "Buy" Rating for Disc Medicine (NASDAQ:IRON)HC Wainwright reaffirmed a "buy" rating and issued a $118.00 price target on shares of Disc Medicine in a report on Tuesday.January 21, 2025 | marketbeat.comDisc Medicine's (IRON) "Outperform" Rating Reiterated at WedbushWedbush reiterated an "outperform" rating and set a $90.00 target price (up previously from $83.00) on shares of Disc Medicine in a research report on Tuesday.January 21, 2025 | marketbeat.comDisc Medicine Announces Successful Type C Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP) and Shares Plans for NDA SubmissionJanuary 21, 2025 | globenewswire.comDisc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)January 20, 2025 | globenewswire.comDisc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)January 17, 2025 | globenewswire.comDisc Medicine's SWOT analysis: rare blood disorder stock shows promiseJanuary 17, 2025 | msn.comDisc Medicine (NASDAQ:IRON) Earns "Outperform" Rating from WedbushWedbush reiterated an "outperform" rating and issued a $83.00 price target on shares of Disc Medicine in a report on Friday.January 10, 2025 | marketbeat.comDisc Medicine Highlights Recent Achievements Across Hematology Portfolio and Key Business Objectives and Milestones for 2025January 10, 2025 | markets.businessinsider.comDisc Medicine, Inc. (NASDAQ:IRON) Insider Sells $470,625.00 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider Rahul Khara sold 7,500 shares of the business's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $62.75, for a total transaction of $470,625.00. Following the completion of the transaction, the insider now directly owns 14,035 shares of the company's stock, valued at $880,696.25. The trade was a 34.83 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.January 6, 2025 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Buy" from BrokeragesShares of Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) have earned an average rating of "Buy" from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation and one has given a stronJanuary 4, 2025 | marketbeat.comInsider Selling: Disc Medicine, Inc. (NASDAQ:IRON) CEO Sells 13,012 Shares of StockJanuary 3, 2025 | insidertrades.comJohn D. Quisel Sells 13,012 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CEO John D. Quisel sold 13,012 shares of the stock in a transaction dated Monday, December 30th. The stock was sold at an average price of $61.95, for a total transaction of $806,093.40. Following the sale, the chief executive officer now owns 72,065 shares of the company's stock, valued at $4,464,426.75. This trade represents a 15.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.January 2, 2025 | marketbeat.comAn Intrinsic Calculation For Disc Medicine, Inc. (NASDAQ:IRON) Suggests It's 29% UndervaluedJanuary 1, 2025 | finance.yahoo.comGeode Capital Management LLC Purchases 70,983 Shares of Disc Medicine, Inc. (NASDAQ:IRON)Geode Capital Management LLC boosted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 17.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 474,719 shares of the company's stock after acqDecember 28, 2024 | marketbeat.comBarclays PLC Has $1.97 Million Holdings in Disc Medicine, Inc. (NASDAQ:IRON)Barclays PLC lifted its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 123.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,145 shares of the company's stock after buying an aDecember 27, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) CEO Sells $1,251,434.80 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CEO John D. Quisel sold 19,820 shares of the company's stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $63.14, for a total value of $1,251,434.80. Following the completion of the sale, the chief executive officer now owns 72,065 shares in the company, valued at approximately $4,550,184.10. This represents a 21.57 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.December 26, 2024 | marketbeat.comDisc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by State Street CorpState Street Corp grew its holdings in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 39.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 827,910 shares of the company's stock after acquiring an additional 235,115 shares during the quarter. StaDecember 21, 2024 | marketbeat.comDisc Medicine (NASDAQ:IRON) Stock Price Down 3% - Should You Sell?Disc Medicine (NASDAQ:IRON) Trading Down 3% - Time to Sell?December 20, 2024 | marketbeat.comJohn D. Quisel Sells 12,791 Shares of Disc Medicine, Inc. (NASDAQ:IRON) StockDecember 19, 2024 | insidertrades.comDisc Medicine, Inc. (NASDAQ:IRON) CEO Sells $844,333.91 in StockDisc Medicine, Inc. (NASDAQ:IRON - Get Free Report) CEO John D. Quisel sold 12,791 shares of the company's stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $66.01, for a total value of $844,333.91. Following the sale, the chief executive officer now owns 72,065 shares of the company's stock, valued at $4,757,010.65. This trade represents a 15.07 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.December 18, 2024 | marketbeat.comY Intercept Hong Kong Ltd Takes $445,000 Position in Disc Medicine, Inc. (NASDAQ:IRON)Y Intercept Hong Kong Ltd acquired a new position in Disc Medicine, Inc. (NASDAQ:IRON - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 9,057 shares of the company's stock, valued at approximately $445,000. A number of other large investors hDecember 17, 2024 | marketbeat.comPromising Pipeline Developments Bolster Buy Rating for Disc MedicineDecember 11, 2024 | markets.businessinsider.com Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address IRON Media Mentions By Week IRON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRON News Sentiment▼-0.850.60▲Average Medical News Sentiment IRON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRON Articles This Week▼75▲IRON Articles Average Week Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Axsome Therapeutics News Blueprint Medicines News Telix Pharmaceuticals Limited American Depositary Shares News Elanco Animal Health News Lantheus News Nuvalent News Cytokinetics News Verona Pharma News Grifols News TG Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRON) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRON Stock Alerts